WASHINGTON — As millions of Americans demand lower drug prices, momentum continues to build for policy changes out of the House and Senate. Three House committees voted to advance HR 3, two Republican senators announced their strong support for the Senate Finance Package, and patients spoke up in a multi-million dollar ad campaign urging Washington to rein in skyrocketing drug prices without delay.

“The past week demonstrates that the power of millions of Americans demanding lower drug prices can overcome Big Pharma’s false claims and fear mongering,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Americans are done listening to pharma’s tired lies and are pushing their elected officials to act immediately.”

In the past week, America has witnessed:

Polling shows Americans say lowering drug prices should be Congress’s top priority among all health issues. Almost 90 percent of Americans support allowing the government to negotiate directly with drug corporations. Four out of five Americans blame high drug company profits for high prices. Three out of four Americans don’t trust drug companies to price their products fairly.